Maryland Capital Management Pure Bioscience, Inc. Transaction History

Maryland Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 11, 2020	SELL	$0.23 - $0.3 $12,933 - $16,869	-56,231 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$0.27 - $0.35 $1,350 - $1,750	5,000 Added 9.76%	56,231 $17,000
Q1 2019 May 13, 2019	BUY	$0.35 - $0.5 $901 - $1,288	2,577 Added 5.3%	51,231 $25,000
Q4 2018 Feb 13, 2019	BUY	$0.36 - $0.65 $11,215 - $20,250	31,154 Added 178.02%	48,654 $18,000
Q3 2018 Nov 13, 2018	BUY	$0.5 - $0.72 $2,500 - $3,600	5,000 Added 40.0%	17,500 $9,000
Q2 2018 Aug 13, 2018	BUY	$0.6 - $0.75 $7,500 - $9,375	12,500 New	12,500 $8,000

Ticker PURE
Exchange OTC
Sector Consumer Defensive
Industry Household & Personal Products
Shares Outstandng 88,023,104
Market Cap $7.92M
Description
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual prot...

Get notified when there are updates to the investment portfolio of Maryland Capital Management, based on Form 13F filings with the SEC.

Stay updated on Maryland Capital Management with notifications on news.